ICICI Securities Ltd | Retail Equity Research Revenues declined 13.9% YoY to | 3235 crore (I-direct estimate: | 3912 crore) mainly due to 16.2% decline in US sales. The US sales decline was primarily on account of increased competition in gValcyte and gVidaza. RoW sales declined 52.7% YoY to | 128 crore primarily on account of zero sales in Venezuela EBITDA margins declined to 12.0% (I-direct estimate: 23.3%) against 26.6% in Q1FY16 on account of higher operational expenditure...